No Data
No Data
Geron to Announce Second Quarter 2024 Financial Results on August 8, 2024
Geron Corporation (NASDAQ:GERN), a commercial-stage biopharmaceutical company, today announced that it will release its second quarter 2024 financial results and business highlights before the market opens on Thursday,
Institutional Investors Control 61% of Geron Corporation (NASDAQ:GERN) and Were Rewarded Last Week After Stock Increased 5.5%
Key Insights Given the large stake in the stock by institutions, Geron's stock price might be vulnerable to their trading decisions 51% of the business is held by the top 14 shareholders
Geron(GERN.US) Officer Sells US$3.07 Million in Common Stock
$Geron(GERN.US)$ Officer GRETHLEIN ANDREW J sold 674.35K shares of common stock on Jul 8, 2024 at an average price of $4.557 for a total value of $3.07 million.Source: Announcement What is statement
Form 144 | Geron(GERN.US) Officer Proposes to Sell 2.93 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 8, $Geron(GERN.US)$、$GERON CORP C/WTS 31/12/2025 (TO SUB FOR ORD)(GERNW.US)$ Officer GRETHLEIN ANDREW J intends to sell 674.35K shares of its common stock on Jul 8, with a
Wuchan Zhongda Geron Anticipates 56% to 66% Higher Net Profit in H1; Shares Rise 6%
Wuchan Zhongda Geron (SHE:002722) anticipated its attributable net profit to reach 80 million yuan to 85.2 million yuan in the first half of the year, a 56% to 66% increase from the 51.2 million yuan
Wuchan Zhongda Geron Co.,Ltd. (SZSE:002722) Pays A CN¥0.19 Dividend In Just Three Days
Wuchan Zhongda Geron Co.,Ltd. (SZSE:002722) stock is about to trade ex-dividend in 3 days. Typically, the ex-dividend date is one business day before the record date which is the date on which a comp